MAIA Biotechnology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 1.10 M | $1.70 M | -3.30% | 3.64% |
| CENTRIC WEALTH MANAGEMENT | 11/04/2025 | 574.90 K | $712.87 K | 0.26% | 1.90% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 271.06 K | $417.53 K | 22.00% | 0.89% |
| MARSHALL WACE, LLP | 11/13/2025 | 110.47 K | $170.12 K | 583.37% | 0.36% |
| BLACKROCK, INC. | 11/12/2025 | 104.86 K | $161.48 K | 1.54% | 0.35% |
| STATE STREET CORP | 11/14/2025 | 75.55 K | $116.35 K | 0.00% | 0.25% |
| NORTHERN TRUST CORP | 11/14/2025 | 39.03 K | $60.11 K | 0.00% | 0.13% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 36.00 K | $55.44 K | 0.00% | 0.12% |
| CENTERPOINT ADVISORY GROUP | 11/04/2025 | 15.73 K | $24.22 K | 0.00% | 0.05% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10/29/2025 | 14.80 K | $26.49 K | 0.00% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 11.62 K | $17.89 K | 100.00% | 0.04% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 8.33 K | $12.83 K | 0.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 4.03 K | $6.20 K | 117.98% | 0.01% |
| CURIO WEALTH, LLC | 11/13/2025 | 2.00 K | $3.08 K | 100.00% | 0.01% |
| MORGAN STANLEY | 11/14/2025 | 832 | $1.28 K | -83.67% | 0.00% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 675 | $1.04 K | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 530 | $816 | 100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 228 | $369 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 29 | $45 | -87.45% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
MAIA Biotechnology, Inc. institutional Ownership - FAQ's
During the previous two years, 25 institutional investors and hedge funds held shares of MAIA Biotechnology, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 1.1 M
Centric Wealth Management: 574,898
GEODE CAPITAL MANAGEMENT, LLC: 271,056
MARSHALL WACE, LLP: 110,467
BlackRock, Inc.: 104,857
STATE STREET CORP: 75,550
7.83% of MAIA Biotechnology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.45 M shares in the last 24 months. This purchase volume represents approximately $4.23 M in transactions.